Interventional firm Guidant has entered into a corporate integrity agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services. The move is the final step in the resolution of the settlement between the Indianapolis-based company’s EndoVascular Technologies subsidiary and the U.S. Department of Justice, which was previously announced on June 12.
Under the terms of the agreement, Guidant will maintain a robust compliance program built around comprehensive policies, procedures, and training. EndoVascular Technologies will focus its compliance activities on complaint handling and medical device reporting. The agreement is effective immediately, Guidant reported.
By AuntMinnie.com staff writers
July 1, 2003
Related Reading
Guidant to stop selling aortic aneurysm device, close unit, June 17, 2003
Guidant admits to hiding defects in endovascular aneurysm-repair system, June 13, 2003
Guidant found to infringe on Cordis patent, June 5, 2003
Guidant debuts RX AccuNet in Europe, May 8, 2003
Guidant to acquire additional Biosensor technology, March 20, 2003
Copyright © 2003 AuntMinnie.com
